Charles River Laboratories International, Inc. CRL
292.84
(1.60)
(0.54%)
as of 25 Sep
- Market cap
- $14.1B
- P/E
- 0.0×
Follow CRL
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Charles River Laboratories International, Inc. (CRL) Free cash flow margin
Charles River Laboratories International, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 9.27%, down 3.6 percentage points from fiscal 2025 (12.9%). Over the past ten years it has ranged from 7.42% (fiscal 2022) to 17.9% (fiscal 2015); the current reading is higher than 45% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 12.9% | 0.52 |
| FY2024 | 12.4% | 3.54 |
| FY2023 | 8.85% | 1.43 |
| FY2022 | 7.42% | (7.61) |
| FY2021 | 15.0% | 2.03 |
| FY2020 | 13.0% | 0.01 |
| FY2019 | 13.0% | (0.30) |
| FY2018 | 13.3% | 0.60 |
| FY2017 | 12.7% | (2.87) |
| FY2016 | 15.6% | (2.31) |
Against its own ten years
Low 7.42%
High 17.9%
Ten-year median
13.0%
Current reading's percentile
45
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 25.4% |
| QGEN QIAGEN N.V. compare | 21.0% |
| RVTY Revvity Inc. compare | 19.6% |
| DGX Quest Diagnostics Incorporated compare | 11.7% |
| ICLR ICON PLC compare | 10.7% |
| CRL Charles River Laboratories International, Inc. | 9.27% |
| LH Labcorp Holdings Inc. compare | 8.16% |
| GH Guardant Health, Inc. compare | −20.4% |
| TWST Twist Bioscience Corporation compare | −22.2% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on CRL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement